About Bruce McCormick
Bruce McCormick co-founded Mercury Bio and serves as its chief executive officer and a director. Mercury Bio develops medicines that enter cells affected by Parkinson’s and Alzheimer’s disease. He has more than 43 patents. Popular Science and The New York Times covered his work, and the U.S. Patent and Trademark Office Museum displayed his insulation technology.
Earlier, he was president and chief technology officer of SAVSU Technologies, where he created SAVSU EVO for ultra-cold transport of therapies, including Zolgensma. He later became senior vice president of Cold Chain Technologies at BioLife Solutions, where he helped build delivery infrastructure for cell and gene therapies worldwide. He also served as president of Air Guard Medical. His first invention led to work with NASA’s EVA group in Antarctica and an FDA-cleared device for cardiac and pulmonary uses. His inventions span motion analysis, cryogenic materials and tools used to deliver vaccines and advanced therapies.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Bruce McCormick in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Bruce McCormick works with at each company, as listed on that company's latest Form D.
